Current Infectious Disease Reports

, Volume 4, Issue 4, pp 332–338 | Cite as

Management of increased intracranial pressure in cryptococcal meningitis

  • Kimberly J. Gambarin
  • Richard J. Hamill


Therapy of cryptococcal meningitis has been focused primarily on optimizing the antifungal regimen to improve the previously high treatment failure rates. Until recently, relatively little attention has been paid to the impact of increased intracranial pressure, which is a frequent problem that complicates management of patients with cryptococcal meningitis. Patients with elevated baseline opening pressures have higher titers of cerebrospinal fluid cryptococcal capsular polysaccharide antigen, more frequent headaches, meningismus, papilledema, hearing loss, and pathologic reflexes, as well as increased morbidity and mortality compared with those patients with normal opening pressures. Optimal therapy has not yet been firmly established, but the diagnostic evaluation and available treatment options are reviewed here, including frequent high volume lumbar punctures, lumbar drains, ventriculoperitoneal shunting, and corticosteroids.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Lipovsky MM, Hoepeman AIM: Opportunistic fungi. In Infectious Diseases. Edited by Armstrong D, Cohen J. London: Mosby; 1999:8.26.1–8.26.16.Google Scholar
  2. 2.
    Fessler RD, Sobel J, Guyot L, et al.: Management of elevated intracranial pressure in patients with cryptococcal meningitis. J Acquir Immune Defic Syndr Hum Retrovir 1998, 17:137–142.Google Scholar
  3. 3.
    Bennett JE, Dismukes W, Duma RJ, et al.: A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med 1979, 301:126–131.PubMedCrossRefGoogle Scholar
  4. 4.
    Saag MS, Graybill RJ, Larsen RA, et al.: Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 2000, 30:710–718. Infectious Diseases Society of America guidelines formulated by members of the NIAID Mycoses Study Group that provide evidencebased recommendations for therapy of cryptococcal disease.PubMedCrossRefGoogle Scholar
  5. 5.
    Graybill JR, Sobel J, Saag M, et al.: Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. Clin Infect Dis 2000, 30:47–54. An important report that demonstrated the relationship of high CSF cryptococcal antigen titers to elevated intracranial pressures and demonstrated the survival benefits of measures to decrease these pressures.PubMedCrossRefGoogle Scholar
  6. 6.
    Van der Horst CM, Saag MS, Cloud GA, et al.: Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med 1997, 337:15–21.PubMedCrossRefGoogle Scholar
  7. 7.
    Saag MS, Powderly WG, Cloud GA, et al.: Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992, 326:83–89.PubMedCrossRefGoogle Scholar
  8. 8.
    Malessa R, Krams M, Hengge U, et al.: Elevation of intracranial pressure in acute AIDS-related cryptococcal meningitis. Clin Invest 1994, 72:1020–1026.CrossRefGoogle Scholar
  9. 9.
    Gottfredsson M, Perfect JR: Fungal meningitis: Semin Neurol 2000, 20:307–322.PubMedCrossRefGoogle Scholar
  10. 10.
    Powderly WG: Current approach to the acute management of cryptococcal infections. J Infect 2000, 41:18–22.PubMedCrossRefGoogle Scholar
  11. 11.
    Denning DW, Armstrong RW, Lewis BH, Stephens DA: Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. Am J Med 1991, 91:267–272.PubMedCrossRefGoogle Scholar
  12. 12.
    Park MK, Hospenthal DR, Bennett JE: Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting. Clin Infect Dis 1999, 28:629–633.PubMedGoogle Scholar
  13. 13.
    Powderly WG, Cloud GA, Dismukes WE, Saag MS: Measurement of cryptococcal antigen in serum and cerebrospinal fluid: Value in the management of AIDS-associated cryptococcal meningitis. Clin Infect Dis 1994, 18:789–792.PubMedGoogle Scholar
  14. 14.
    Tien RD, Chu PK, Hesselink JR, et al.: Intracranial cryptococcosis in immunocompromised patients: CT and MR findings in 29 cases. AJR 1991, 156:1245–1251.Google Scholar
  15. 15.
    Miszkiel KA, Hall-Craggs MA, Miller RF, et al.: The spectrum of MRI findings in CNS cryptococcosis in AIDS. Clin Radiol 1996, 51:842–850.PubMedCrossRefGoogle Scholar
  16. 16.
    Antinori S, Ridolfo AL, Gianelli E, et al.: The role of lumbar puncture in the management of elevated intracranial pressure in patients with AIDS-associated cryptococcal meningitis. Clin Infect Dis 2000, 31:1309–1310.PubMedCrossRefGoogle Scholar
  17. 17.
    Chan KH, Mann KS, Yue CP: Neurosurgical aspects of cerebral cryptococcosis. Neurosurgery 1989, 25:44–48.PubMedCrossRefGoogle Scholar
  18. 18.
    Crum CP, Feldman PS: Cryptococcal peritonitis complicating a ventriculoperitoneal shunt in unsuspected cryptococcal meningitis. Hum Pathol 1981, 12:660–661.PubMedCrossRefGoogle Scholar
  19. 19.
    Mylonakis E, Merriman NA, Rich JD, et al.: Use of cerebrospinal fluid shunt for the management of elevated intracranial pressure in a patient with active AIDS-related cryptococcal meningitis. Diagn Microbiol Infect Dis 1999, 34:111–114.PubMedCrossRefGoogle Scholar
  20. 20.
    Bach MC, Tally PW, Godofsky EW: Use of cerebrospinal fluid shunts in patients having acquired immunodeficiency syndrome with cryptococcal meningitis and uncontrollable intracranial hypertension. Neurosurgery 1997, 41:1280–1283.PubMedCrossRefGoogle Scholar
  21. 21.
    Diamond RD, Bennett JE: A subcutaneous reservoir for intrathecal therapy of fungal meningitis. N Engl J Med 1973, 288:186–188.PubMedCrossRefGoogle Scholar
  22. 22.
    Polsky B, Depman MR, Gold JWM, et al.: Intraventricular therapy of cryptococcal meningitis via a subcutaneous reservoir. Am J Med 1986, 81:24–28.PubMedCrossRefGoogle Scholar
  23. 23.
    Shelburne SA III, Hamill RJ, Rodriguez-Barradas MC, et al.: Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine 2002, 81:213–227. A review of the various clinical situations and manifestations of the immune reconstitution inflammatory syndrome that arises after HAART in patients with prior successfully treated infectious syndromes, including cryptococcal meningitis. Suggestions for treatment are addressed.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2002

Authors and Affiliations

  • Kimberly J. Gambarin
  • Richard J. Hamill
    • 1
  1. 1.Infectious Diseases SectionVeterans Affairs Medical Center (111G)HoustonUSA

Personalised recommendations